Oral administration of the GnRH [gonadotropin-releasing hormone] antagonist acyline in normal men.
Phase of Trial: Phase I
Latest Information Update: 02 Dec 2010
At a glance
- Drugs Acyline (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Pharmacodynamics
- 16 Jan 2008 Status change from in progress to completed.
- 16 Aug 2007 Status changed from recruiting to in progress.
- 20 Jul 2007 New trial record.